AEON Biopharma, Inc.
Pharmaceutical ManufacturingView the employees at
AEON Biopharma, Inc.-
Kaylyn M. Manager, Financial Planning & Analysis
-
Newport Beach, California, United States
-
Rising Star
Kaylyn M. Manager, Financial Planning & Analysis-
Rising Star
Dr. Najeebah Abdul-Musawir, MD, MBA, MScEng Senior Medical Director, Clinical Development and Medical Affairs-
Top 10%
Marc Forth President and Chief Executive Officer at AEON Biopharma, Inc.-
Irvine
-
Top 5%
Overview
AEON Biopharma is a biopharmaceutical company focused on developing ABP-450 (prabotulinumtoxinA) injection for the treatment of debilitating medical conditions. The company is dedicated to innovation in the rapidly expanding therapeutic botulinum toxin market. This therapeutic-only focus will allow AEON Biopharma to advance safe and effective treatment options to patients, while delivering differentiated economics to payors and physicians. The company continues to evaluate additional therapeutic indications for development based on a comprehensive product assessment process designed to identify those indications where it believes ABP-450 can attain clinical, regulatory and commercial success.
-